Creative Medical Technology Holdings, Inc. (CELZ)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | — | ||
| 10-Q | Q1-2026 | — | ||
| 10-K/A | FY-2025 | |||
| 10-KLatest | FY-2025 | — | ||
| 10-Q | Q3-2025 | — | ||
| 10-Q | Q2-2025 | — | ||
| 10-Q | Q1-2025 | — | ||
| 10-K/A | FY-2024 | |||
| 10-K/A | FY-2025 | |||
| 10-K/A | FY-2024 | |||
| 10-K | FY-2024 | — | ||
| 10-Q | Q3-2024 | — | ||
| 10-Q | Q2-2024 | — | ||
| 10-Q | Q1-2024 | — | ||
| 10-K/A | FY-2023 | |||
| 10-K | FY-2023 | — | ||
| 10-Q | Q3-2023 | — | ||
| 10-K/A | FY-2022 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | ||
| Statements | ||
| Consolidated Balance Sheets | ||
| Unaudited Condensed Consolidated Balance Sheets | — |
|
| Consolidated Balance Sheets (P) | ||
| Unaudited Condensed Consolidated Balance Sheets (P) | — |
|
| Consolidated Statements of Operations | — |
|
| Unaudited Condensed Consolidated Statements of Operations | — |
|
| Consolidated Statements of Stockholders' Equity (deficit) | — |
|
| Unaudited Condensed Consolidated Statements of Cash Flows | — |
|
| Consolidated Statements of Cash Flows | — |
|
| Unaudited Condensed Consolidated Statements of Stockholders' Equity | — |
|
| Unaudited Condensed Consolidated Statements of Stockholders' Equity (deficit) | — |
|
| Notes | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Debt | — |
|
| Derivative Liabilities | — |
|
| Income Taxes | — |
|
| Insider Trading Arrangements | ||
| Licensing Agreements | ||
| Note Receivable | ||
| Organization and Summary of Significant Accounting Policies | ||
| Related Party Investment | — |
|
| Related Party Transactions | ||
| Significant Research and Development Purchases | ||
| Stock-based Compensation | ||
| Stockbased Compensation | ||
| Stockholders Equity | ||
| Subsequent Events | ||